Skip to main content

Table 4 Emerging trends of originator medicines

From: Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis

  Trend 1 Trend 2 Trend 3
Global Core 1. Ventolin® 5. Zocor 4. Capoten
2. Daonil® 7. Ciprobay 6. Tryptanol
3. Tenormin 14. Losec 9. Amoxil
8. Bactrim   
10. Rocephin   
11. Valium   
12. Voltaren   
13. Panado   
Regional Core 16. Norvasc 25 Glucophage 15 Albendazolea
17. Lipitor 20 Renitec 18 Becotide a
21. Prozac   19 Keflex
26. Flagyl   22 Diamicron
27. Adalat Retard   23 Dichloride
28. Zantac   24 Brufen
29. Epilim   
Supplementary 30. Zovirax 34. Diflucan 39. Crestorb
31. Tegretol 45. Lenamet 43. Erythrocin
32. Augmentin   
33. Lanoxin   
35. Nizoral   
36. Cozaar   
37. Epanutin   
38. Rimactane   
40. Tarivid   
41. Aminophylline   
42. Daktarin   
44. Zithromax   
46. Zestril   
47. Clarityne   
48. Fortum   
49. Ismo   
50. Eltroxin   
30. Zovirax   
31. Tegretol   
32. Augmentin   
33. Lanoxin   
35. Nizoral   
36. Cozaar   
37. Epanutin   
38. Rimactane   
40. Tarivid   
  1. aChange in dosage form
  2. bManufactured in 2006
Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us